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WEBINAR
A criminal justice-engaged research collaborative:
Findings and lessons learned from Western Massachusetts
• Everyone will be muted upon entry.
• Please use the Q&A for questions.
• Questions will be answered following the presentation.
We will be starting shortly.  While waiting, please enter your name and organization into the 
chat box.
Welcome!
Community Engagement and Collaboration Core
UMass Center for Clinical and Translational Science
Ed Hayes, Assistant Superintendent
Franklin County Sheriff’s Office
Liz Evans, PhD, MA, Associate Professor
University of Massachusetts Amherst
A criminal justice-engaged research collaborative: 
Findings and lessons learned 
from Western Massachusetts
9th Annual Community Engagement and Research Symposium
UMass Center for Clinical and Translational Science
October 14, 2020 at 1pm
Franklin County Sheriff’s Office University of Massachusetts Amherst
• Ed Hayes, Assistant Superintendent
• Levin Schwartz, LICSW, Assistant Deputy Superintendent
• Nickey Guertin, LICSW, MSW
• Louis Freilicher, Community Health Worker
• Liz Evans, PhD, MA, Associate Professor
• Calla Harrington, LCSW, MSW, MPH, Research Fellow
• Elizabeth Delorme, Research Fellow
Context
 National need to expand capacity to deliver medications to treat 
opioid use disorder (MOUD), especially for criminal-justice involved 
individuals.
 Two Houses of Corrections in Western Massachusetts (HOC, jail), 
mostly rural.
• In 2015, Franklin County HOC began providing buprenorphine, in 
addition to naltrexone.
• Services included buprenorphine induction and continuation at 
jail entry.  
• Initially focused on sentenced individuals, later included pre-trial 
individuals.
• At the same time, Hampshire HOC was providing naltrexone, mostly 
at HOC exit, and no buprenorphine.
• Impetus for three projects.
(New England Public Radio, Jeff Brown/MASSLIVE 2019) 
(New England Public Radio, The Republican/MASSLIVE 
2018)
Project 1: Expand jail capacity for MOUD delivery and community re-entry
• The Franklin County Sheriff’s Office (FCSO)  was awarded a grant to implement and evaluate a 
program over three years (2018-2021)
• Funded by Substance Abuse and Mental Health Services Administration (SAMHSA), Center 
for Substance Abuse Treatment (CSAT), Grant No. 1H79T1081387
• Program component
• Expand capacity to provide medications to treat opioid use disorder (MOUD) to people living in 
Franklin and Hampshire County jails, both during and after incarceration (n=300)
• Implement a comprehensive community reentry program
• Strengthen community-partnerships
• Evaluation component
• FCSO contracted with UMass Amherst to conduct program evaluation and research
• Assess MOUD adoption by jails
• Assess MOUD utilization and outcomes among patients
Project 1: An example of community-based participatory research
Wallerstein et al 2018 Community-Based Participatory Research for Health: Advancing Social 
and Health Equity 3rd edition San Francisco, CA: Wiley
Project 1: Platform for timely pivots
Commentary “COVID-19 and treating incarcerated populations for opioid use disorder”
Christopher J. Donelan, MPA1, Ed Hayes,1 Ruth A. Potee, MD,1 Levin Schwartz, LICSW,1 Elizabeth A. Evans, PhD, MA2 
Project 2: Post-release opioid use trajectories after MOUD in jail
Funded by NIDA 3UG3DA044830-02S1, 2018-2019 (NCE 2021), PI: Peter Friedmann, MD; Co-I Liz Evans, PhD
• Natural experiment
• Research questions
o What are the post-release outcomes of 
individuals who received MOUD while 
incarcerated (pre-release MOUD 
condition) versus individuals who did not 
receive MOUD while incarcerated 
(controls)?
o Which individual characteristics and 
treatment factors are associated with 
post-release MOUD access, utilization, 
and outcomes among study participants 
who did and did not receive MOUD while 
incarcerated?
1-4 year follow-up of 500 adults with OUD, exited jail Jan 2015-Apr 2019: 
n=250 received MOUD while at Franklin HOC
n=250 did not receive MOUD while at Hampshire HOC
Master list & initial contact
Contracted jail staff will identify sample, 
locate (deceased, incarcerated, alive), 
conduct initial contact
Biological samples
Research staff will collect saliva/blood 
from sub-sample (n=50) and test for 
substance use and infectious disease 
(HIV/HCV/syphilis)
Securing administrative data
If available and accessible, obtain 
electronic records on all prospective 
participants (n=500)
•National Death Index 
– Date & cause of death (ICD-10)
•Jail records
– MOUD and other addiction treatment
– Criminal justice system
– Health records
Outcomes
Primary: opioid use trajectories 1-4 years post-release from jail
Secondary: mortality, MOUD access and utilization in the community, recidivism, 
infectious disease
Follow-up interview 
Research staff will conduct interview by 
telephone
MOUD: medications for opioid use disorder
Project 2: Building research capacity 
Learn about existing administrative data by mining it to define the sample
• Goal: all adults with opioid use disorder (OUD) who exited the two participating jails Jan 2015 – April 
2019.  
• Did record review August 2018 – Sept 2020.
• Analyzed existing administrative data to identify all adults with OUD who exited in our time frame.
• Verified information by hand, relying on electronic medical records cross-checked against other 
criminal justice records.
o has OUD
o whether received MOUD while in jail
o date of jail exit
o other information
• Reviewed criminal justice records by hand to extract indicators of recidivism.
o Covers events occurring in Massachusetts. 
o Data extracted in Oct 2019. Verified in Sept 2020.
• Total n=469; n=315 (67.2% of total) has >1 year of observation after jail exit.
Project 2: Building research capacity 
Conduct follow-up interviews with individuals who exited jail
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Project 2: Building research capacity
Group dynamics in action
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NIH HEAL Initiative and Helping to End Addiction Long-term are service marks of the U.S. Department of Health and 
Human Services.
Recidivism after 
MOUD in Jail:
Preliminary results
PI: Peter Friedmann, MD, UMMS Baystate
Co-I: Elizabeth Evans, PhD, UMass Amherst
NIDA  3UG3DA044830-02S1
JCOIN Steering Cmte Meeting, 9/29/20, 1pm
Preliminary results: Time from jail exit to first recidivism event
among sample that has >1 years of obs after jail exit (n=315), unadjusted survival analysis with 95% Hall-Wellner bands
Cox proportional hazards ratio 
(Hampshire vs. Franklin): 
1.66 (1.19, 2.32), p=0.01.
Interpretation: The expected risk 
of recidivism is 1.66 times higher 
in Hampshire than in Franklin. 
Adjusted for age, jail status, prior 
incarcerations: 
1.86 (1.27, 2.73), p = 0.01.
Restricted to white males only and 
controlling for age: 
1.81 (1.25, 2.63), p=0.01.
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+ Censored
Recidivism is defined as any incarceration, probation violation, or arraignment that occurred after exit from jail on index episode.
Project 3: Massachusetts Justice Community Opioid Innovation Network 
Research Hub (MassJCOIN)
• Massachusetts is the first state to mandate county jails to deliver 
all FDA-approved MOUDs.
• MassJCOIN was funded by NIDA, 2019-2024.
• mPIs: Peter Friedmann, MD and Elizabeth Evans, PhD
• Three interrelated aims
o Longitudinal treatment outcomes 
o Implementation study
o Economic evaluation
KEY EXPLANATORY VARIABLE
• In-jail MOUD delivery: 
o XR-NTX, BUP-NX, 
methadone, no MOUD
PRIMARY OUTCOMES
•MOUD initiation post-release
•MOUD engagement post-release
•MOUD retention
SITE-LEVEL, OUD CASCADE 
PERFORMANCE METRICS
In-jail
• OUD screen rate
• OUD screen positive rate
• MOUD assessment rate
• MOUD referral rate
• MOUD initiation rate
In-community 
• OUD appointment rate
• OUD appointment show rate
Post-release 
• MOUD initiation rate
• MOUD engagement rate
• MOUD retention rate
MassJCOIN Aim 1. Longitudinal treatment outcome study
SECONDARY OUTCOMES
• Time-to-overdose
• Opioid overdose fatalities
• ED and hospital utilization
• All-cause mortality
• Reincarceration
• Rearrest
OTHER EXPLANATORY 
VARIABLES
• Behavioral SUD and MH treatment
• Recovery support services
• Demographic characteristics
• OUD-related consequences in 
year prior to detention
N~7500 detainees with OUD will be eligible over 18 months, ~10%-20% will receive MOUD.
CLIMATE
• Type of agency
• Staffing
• EPIS
IMPLEMENTATION OUTCOMES
• No. screened and assessed
• No. served by MOUD or other BH tx in county
• No. provided care coordination post-release
MassJCOIN Aim 2. Implementation study
IMPLEMENTATION PROCESSES & CRITICAL INCIDENTS
(Triangulation, enriched description, fidelity, cost)
• Processes, critical incidents
• Fidelity to MOUD implementation strategies
• Economic study
TARGET MECHANISMS
• Implementation strategies
• Performance monitoring
• Interagency teams
• Common goals and mission
• System integration
N = key stakeholders, staff, and detainees in 7 jails; 5 Waves (Months 6, 18, 36, 48, 55).
CLIMATE
• Attitudes towards EBPs
• Organizational culture
• Support for innovations
• Perception of policy
MassJCOIN Aim 3. Economic evaluation
• Cost to the correctional 
system of implementing 
MOUD in jail
• From state-policymaker 
and societal 
perspectives, compare 
the value of MOUD prior 
to release from jail to no 
MOUD among matched 
controls
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Northeastern University
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2. RA Atsushi Matsumoto
George Mason University
1. Co‐I Faye Taxman, PhD
Massachusetts Justice Community Opioid Innovation Network (MA‐JCOIN) Clinical Research Center  
Grant DA050067
Principal Investigators: Peter D. Friedmann, MD, MPH, FASAM, DFACP & Elizabeth A Evans, PhD, MA
University of Miami
1. Co‐I Kathryn McCollister, PhD
2. RA Ivan Montoya
Cornell University
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2. RA Danielle Ryan
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JCOIN Participating Houses of Correction Non‐JCOIN Houses of Corrections
JCOIN Vision & Priority Goals
Every individual involved in the justice system with a substance 
use disorder should have access to effective treatment, while 
detained and while in the community. 
Vision
• Generate new evidence about what works and how to effectively implement
• Become a go-to resource for researchers and practitioners
• Develop a network of researchers collaborating with practitioners across 
justice and community‐based service settings. 
• Build capacity to conduct and apply research in justice settings
• Speed translation of science to solutions and create feedback loops. 
Priority Goals
MASSACHUSETTS 
(MA)
Evaluating state pilot of 
MOUD in jails
JAIL (7)
NYSPI (NY)
Implementing new opioid 
court model
DRUG COURT (10)
INDIANA U (IN)
Learning health systems + 
opioid care cascade
JUVENILE JUSTICE (8)
CHESTNUT (IL)
Adaptive version of Recovery 
Management Checkups NEW YORK UNIV (CT/DE/NH/NJ/OR)
XR-NTX vs Sublocade
JAIL (5)
FRIENDS RESEARCH 
(MD)
x
XR-NTX vs BrixadiJAIL (10)
U of WISCONSIN
(HI/VA/WI)
NIATx vs ECHO 
implementation strategies
JAIL (30)
JAIL (7)
JAIL (6)
U of CHICAGO (IL)
Recovery case management 
+ harm reduction
JAIL (4) / PRISON (2)
U of KENTUCKY (KY)
Telehealth/ MOUD 
engagement for women
JAIL (9)
YALE-HIV (CT/TX)
Peer navigators vs mobile 
health units for OUD+HIV
PROBATION/PAROLE (4)
BROWN U. (NC/PA/RI)
Organizational linkages 
+ peer support
PROBATION/PAROLE (7)
TCU (IL/NM/TX)
Strategies to implement 
opioid tx linkage model
PROBATION/PAROLE (18)
YALE UNIV.
(CT/MN/NY/NC/PR)
CHWs + primary care for 
OUD
I  
STATE POLICY ROLLOUTS
JUVENILE JUSTICE
ORGANIZATIONAL 
IMPLEMENTATION
MOUD COMPARATIVE 
EFFECTIVENESS
LINKAGE FACILITATION
JCOIN has grown and continues to grow!
September 2019:
82 counties
16 states
10 clinical trials
September 2020:
117 counties
27 states
13 clinical trials Hawaii
Puerto Rico
1-5 counties 6-10 counties 11+ counties
Accelerator 
Supplements MAARC
Coordinating 
Center
Research Hubs
Workgroups & 
Committees
JCOIN: The 10,000 Foot View
JCOIN Priority Goals & Components
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•Technical Assistance 
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•Online Training 
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Crosscutting Foundation: Collaborative Network of Researchers and Practitioners
Build Capacity: Engaging New Investigators
• Learn Experiences to Advance Practice (LEAP) Training Program
o Conducted rigorous needs assessment to align program with demand
o 9 JCOIN PI’s as faculty/mentors
o Recruited first cohort: 
 Scholar Track (1 year): 10 practitioner-scholars
 Investigator Track (2 years): 5 researcher-investigators
 55 applications received 
 Participants across a diverse range of perspectives (e.g., social work, law, 
sociology, psychology, nurse practitioner, public health)
o Coordination with Curt Beckwith’s NIDA R25
Leads: Danielle Rudes & Warren Ferguson
JCOIN LEAP Participants
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CDC Genomics and Precision Health; The Intersector Project
A Public Health Conceptual Model
Collaboration is a chance to use your PhD for a purpose
Presented in Shi & Singh, 2015; adapted from Bronfenbrenner,  1979; 1994. Adopted by Healthy People 2020 and the World Health 
Organization (WHO)
Collaboration is a chance to diffuse innovations 
and address “knowledge-do” gaps
Everett Rogers (1962), Diffusion of innovations theory.
How Policy 
Makers Perceive 
Research
How Researchers 
Perceive Policy
How Communities 
and Practitioners 
Perceive Policy 
and Research
Lack of timeliness Decisions based on 
political preferences 
and money
Both disconnected
from real lived 
experiences of the 
persons on whom 
they are doing 
research or for 
whom they are 
making policy
Politically irrelevant 
research
Lack of scientific 
evidence
Research for the 
sake of research
Too much 
partisanship
Too much focus on 
describing and 
managing the 
problem
Manipulation of 
data to support a 
political position or 
agenda
Lack of personal 
contact among 
researchers, policy 
makers, and those 
most affected by 
the problem
Lack of applicability 
to “real-life” 
solutions
Lack of political will 
or action
Not enough action
Stone, C. (2016) in Wallerstein et al 2018 Community-Based Participatory Research for Health: Advancing Social and Health Equity 3rd edition San Francisco, CA: Wiley
Collaboration is a chance to achieve health equity
• Everyone has a fair and just opportunity to 
be as healthy as possible. 
• Requires removing obstacles to health
• poverty, discrimination, and their 
consequences, including 
powerlessness and lack of access to 
good jobs with fair pay, quality 
education and housing, 
safe environments, and health care.
• Reduce and eliminate disparities in health 
and its determinants that adversely affect 
excluded or marginalized groups. 
www.rwjf.org
Keep Going! 
Mechanisms for collaboration: 
A reflective and generative conversation
“Collaborations move at the speed of trust”
Senge et al (2015).  The dawn of system leadership. Stanford Social Innovation Review. 
https://ssir.org/articles/entry/the_dawn_of_system_leadership#
Questions!
Next Webinar
Developing a Strategic Plan for Community Based Research in 
Springfield
Panelists will discuss leveraging existing and potential partnerships towards research that emanates from 
needs of the community and addresses these needs in a systematic, rigorous, and sustainable manner.
October 29, 2020, 3:00 – 4:00 PM
Panel Presenters:
Paul Pirraglia, MD, MPH, Chief of the Division of General Medicine and Community Health at Baystate Medical Center
Andrew Balder, MD, Medical Director, Baystate Mason Square Neighborhood Health Center
Cristina Huebner Torres, PhD, MA, Caring Health Center, Vice President-Research and Population Health
Peter Lindenauer, MD, Assistant Dean for Population Health at the University of Massachusetts Medical School – Baystate
Frank Robinson, PhD, Vice President, Public Health, Baystate Health
Kathleen Szegda, PhD, MPH, MS, Director of Community Research and Evaluation at the Public Health Institute of Western MA
